v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Income Statement [Abstract]    
Net revenues $ 68,731 $ 75,603
Cost of goods sold 69,796 71,935
Gross profit (1,065) 3,668
Research and development expenses 7,462 9,860
Selling, general and administrative expenses 47,672 47,282
Total operating expenses 55,134 57,142
Loss from operations (56,199) (53,474)
Other income (expense), net:    
Interest expense (1,024) (1,015)
Other, net 4,318 123
Total other income (expense), net 3,294 (892)
Loss before taxes (52,905) (54,366)
Income tax expense 0 2
Equity in losses (income) of unconsolidated joint venture 11 (7)
Net loss $ (52,916) $ (54,361)
Net loss per share available to common stockholders—basic (in dollars per share) $ (0.69) $ (0.84)
Net loss per share available to common stockholders—diluted (in dollars per share) $ (0.69) $ (0.84)
Weighted average common shares outstanding—basic (in shares) 76,194,916 64,702,249
Weighted average common shares outstanding—diluted (in shares) 76,194,916 64,702,249